Trader Talks Tradin...
Health Care: Drugs
Pfizer Inc. (PFE: NYSE)
$16.46 0.06 | 0.37%
09/03/10 - 04:00 PM ET
33.01M / 53.63M
Vol / Avg. Vol:16.47 / 16.40
Open / Prev. Close:16.38 - 16.59
Today's Range:14.00 - 20.36
52 Wk Range:-9.51%
Performance YTD:TheStreet Rating:
Portfolios with PFE
- Portfolio NameUser Type
- Contributor10 Stocks Surging During th...
- Contributor4 Dow Stocks With Big Divid...
- Contributor10 Most Attractively Valued...
- Contributor11 Famous Health Care Stock...
- ContributorTop 10 Dow Dividend Stocks
- ContributorBarron's Roundtable Picks &...
- ContributorCharts Of The Week 6-09-2010
- ContributorFast Money's Defensive Stoc...
- ContributorCramer's Dow Stocks Worst-C...
- ContributorCramer's Wrong Hideout Stocks
Latest PFE Headlines from TheStreet
- Jobs Report Has Stocks Seeing Green 09.03.10 | 04:09 pm
- Stock Wrap: The Real Story, September 3
09.03.10 | 04:09 pm - More Hostile Biotech, Pharma Deals 09.03.10 | 10:09 am
- Celldex, Pfizer Split Over Brain Tumor Drug 09.03.10 | 09:09 am
- Cult Stocks: Krispy Kreme's Sweet Comeback 09.03.10 | 08:09 am
- Two Undervalued China Pharma Stocks 09.02.10 | 04:09 pm
- Pfizer and Merck to Make Acquisitions 09.02.10 | 08:09 am
- Pfizer Files Suit Against Mylan 09.01.10 | 11:09 am
- Genzyme Sale Inevitable, Buysiders Say 09.01.10 | 12:09 am
- J&J: More Recalls, More Market Share Loss? 08.31.10 | 01:08 pm
Press Releases for PFE
- Pfizer To Acquire FoldRx Pharmaceuticals - PR Newswire 09.01.10 | 08:09 am
- MS LifeLines® Reaches Milestone Of Servicing One Million In-Bound Calls - PR Newswire 09.01.10 | 08:09 am
- Bristol-Myers Squibb And Pfizer Inc Evaluate Unmet Need In Patients With Atrial Fibrillation - Business Wire 08.25.10 | 08:08 am
- Topline Results From Phase 3 Trial Of Sunitinib With Erlotinib In Advanced Non-Small Cell Lung Cancer (NSCLC) - PR Newswire 08.23.10 | 05:08 pm
- World Health Organization Grants Prequalification To Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine For Infants And Young Children - PR Newswire 08.23.10 | 12:08 pm
- Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A - PR Newswire 08.09.10 | 10:08 am
- Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference - PR Newswire 07.29.10 | 10:07 am
- (Photo: Business Wire) - Business Wire 07.23.10 | 08:07 pm
- Pfizer To Offer Free Public Access To Mental Health Assessment Tools To Improve Diagnosis And Patient Care - PR Newswire 07.22.10 | 12:07 pm
- Pfizer Suspends Chronic Pain Studies In Tanezumab Clinical Trial Program; Some Studies Continue In Areas Of Unmet Medical Need - PR Newswire 07.19.10 | 05:07 pm
Partner Headlines for PFE
- PDLI Gives Third-Quarter Outlook - Analyst Blog - Zacks 09.03.10 | 09:09 am
- An Era of Multiple Compression: A Scenario Analysis and How to Invest in Equities - Seeking Alpha 08.31.10 | 09:08 am
- SMART MONEY PROFILE-A Wall Street fox hunts at Owl Creek - Reuters 08.30.10 | 12:08 pm
- FDA Committee Rejects Expanded Use of Jazz Drug on Abuse Concerns: Biotech's Latest Failures - Seeking Alpha 08.30.10 | 08:08 am
- European Approval for Shire Drug - Analyst Blog - Zacks 08.27.10 | 06:08 pm
- Week Ahead: It's the Jobs, Silly - Fox Business 08.27.10 | 04:08 pm
- Bulls Wave Off Dreary Data; Dow Erases Triple-Digit Slide - Fox Business 08.25.10 | 04:08 pm
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Pfizer's Sutent Fails to Improve Survival in Lung Cancer Patients - Fox Business 08.24.10 | 12:08 pm
- Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, UCB Pharmaceuticals, Pfizer, Eli Lilly and Co. and Forest Laboratories - Press Releases - Zacks 08.24.10 | 08:08 am
